On Invalid Date, Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 2023 earnings per share (EPS) of -$0.89, up 85.24% year over year. Total Kiora Pharmaceuticals earnings for the quarter were -$6.29 million. In the same quarter last year, Kiora Pharmaceuticals's earnings per share (EPS) was -$6.03.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.